OCTOBER 12
8:00-9:00 Registration, coffee and networking
9:00-10:00 Opening plenary session and Keynote speaker (Ziedona Hall)
Robert Green Professor of Medicine (Genetics); Mass General Brigham, Harvard Medical School (USA)
The Path to Universal Genomic Medicine
10:30-12:00 Cancer Genetics and Precision Oncology (Ziedona Hall)
Chair: Sandra Lejniece
Speakers:
David Gisselsson Nord Professor of Molecular Pathology, Vice Dean, Principal Investigator; Lund University Cancer Centre (Sweden)
Topic: TBC
Martin Zoche Director of the Molecular Tumor Profiling, Department of Pathology and Molecular Pathology; University Hospital Zurich (Switzerland)
Merging Clinical Data for Oncology Patients – The challenge of aggregating informative data sets
Brian Bird Consultant Medical Oncologist; Bon Secours Cork, Senior Lecturer; Clinical Education in University College Cork (Ireland)
An ordinary oncologist faced with extraordinary data – how the Irish National on-line MTB helped me and my patients
Aija Linē Latvian Biomedical Research and Study Centre (Latvia)
EVs as a source of cancer-derived biomarkers for liquid biopsies
10:30-12:00 National genomics and precision medicine infrastructure in Nordics+ region (Conference Room 1)
Chair: Mait Metspalu
Speakers:
Asa Johansson Associate Professor; Uppsala University (Sweden)
Precision Medicine roadmap at SciLifeLab
Eero Punkka Director; Helsinki Biobank (Finland)
FinnGenn
Monta Briviba Head of the core facility Genome Center; Latvian Biomedical Research and Study Centre (Latvia)
National genomics initiatives and projects in Latvia
Sander Pajusalu Head of the Genetics and Personalized Medicine Clinic, associate professor; Tartu University Hospital, Tartu University (Estonia)
Implementing Precision Medicine in Estonia
STAKEHOLDER SESSION
10:30-11:30 Human capital development in healthcare (Conference room 2)
Moderator: Raimonds Lapins
Deputy State Secretary on Economic Issues, Ministry of Economics (Latvia)
Panel:
Daiga Behmane
Indrikis Muiznieks
Talis Juhna
Aiga Balode
12:00-13:00 Lunch and networking
13:00-14:30 Pediatric Oncology (Ziedona Hall)
Chair: Elina Dimina TBC
Speakers:
Jelena Rascon Associate Professor, Medical doctor; Faculty of Medicine, Vilnius University, Center for Pediatric Oncology and Hematology at Vilnius University Children’s Hospital (Lithuania)
Initiation of several pediatric oncology clinical trials as part of HE2020 Twinning
Bastiaan Tops Head of Laboratory for Childhood Cancer Pathology; Prinses Máxima Centrum (The Netherlands)
The ultrafast molecular profiling of (pediatric) brain tumors during surgery
Dace Enkure Molecular genetic; Childrens’s Clinical University Hospital (Latvia)
Development of tumor board in Children’s clinical university hospital
13:00-14:30 AI / Big Data in Precision Medicine (Conference Room 1)
Chair: Baiba Vilne
Speakers:
Tero Hiekkalinna Associate professor, senior researcher; Finnish Institute for Health and Welfare (Finland)
1 Millions Genomes project – Simulating 1,000,000 synthetic genome dataset with phenotypes
Markus Perola Research Professor; Finnish Institute for Health and Welfare (Finland)
Topic: TBC
Maija Radzina
Topic: TBC
STAKEHOLDER SESSION
13:00-13:45 Young researchers (LV) (Conference Room 2)
Chair: Una Riekstina and Zanda Daneberga
Egija Berga-Svitina Rīga Stradins University (Latvia)
Exploring genetic factors and polygenic risk scores to predict breast and ovarian cancer risk in BRCA1 pathogenic variant carriers
Vadims Parfejevs University of Latvia
Organoid models in pancreatic tumor studies
Karina Goluba University of Latvia
Human iPSC model to study the orphan diseases: calpainopathy
Karlis Racenis, Riga Stradiņs University (Latvia)
Phage therapy: a personalized approach in the treatment of multi-drug resistant infections
STAKEHOLDER SESSION
13:45-14:30 International Master students (Conference Room 2)
Chair: Asa Johansson
Vika Jaskeviciute
Josephine Heinold
Ivanna Atava
14:30-14:45 Break for refreshments and networking
14:45-15:15 MOU/CONSORTIUM ANNOUNCEMENT TBC (Ziedona hall)
14:45-15:15 Partner Symposium (Conference Room 1)
15:15-15:30 Break for refreshments and networking
15:30-17:00 Functional Precision Medicine (Ziedona Hall)
Chair: Inese Cakstina – Dzerve
Speakers:
Anthony G. Letai Professor of Medicine, Dana Farber Cancer Institute, Harvard Medical School; Associate Member, Broad Institute (USA)
Towards functional precision medicine approach – a general overview of the field
Patrick Bhola Head of Laboratory of Functional Precision Medicine; Harvard Medical School (USA)
Methods in functional precision medicine
Joan Montero Associate Professor; University of Barcelona (Spain)
Overcoming cancer resistance to treatment using functional precision medicine
Caroline Heckman Research Director; Institute for Molecular Medicine Finland (Finland)
Functional precision medicine for hematological malignancies – Finland experience
Paivi Ostling Associate Professor; Karolinska Institute (Sweden)
Precision cancer medicine in solid tumors – Sweden experience. From science to clinic
15:30-17:00 TBC (Conference room 1)
STAKEHOLDER SESSION
15:30-16:30 Next steps in building health economy in Latvia (Conference room 2)
Moderator:
Aiga Balode
Acting State Secretary and Deputy State Secretary for Digitalization and Change Management (Latvia)
Panel:
Gatis Ozols
Iveta Gavare
Normunds Stanevics
Maija Abolina
STAKEHOLDER SESSION
16:30-17:00 Patient engagement (Conference room 2)
Chair: Baiba Ziemele
Speakers:
Begonya Nafria Escalera Patient Engagement in Research Coordinator; Sant Joan de Déu Children’s Hospital (Spain)
Topic: TBC
Roi Shternin Patient advocate, entrepreneur, and author (Israel)
Topic: TBC
17:00-17:30 Networking
OCTOBER 13
8:30-9:00 Registration, coffee and networking
9:00-10:00 Opening plenary session and Keynote speaker (Ziedona Hall)
10:30-12:00 Newborn screening (Ziedona Hall)
Chair: Madara Auzenbaha
Speakers:
Five Year Follow-Up to Newborn Sequencing in the BabySeq Project
Alessandra Ferlini Medical geneticist and neurologist, professor in medical genetics, and director of the Medical Genetics Unit; University of Ferrara (Italy)
Genetic newborn screening as the gateway to genomic medicine
Karit Reinson Doctor-lecturer ; University of Tartu (Estonia)
Newborn screening and its development in Estonia
Svetlana Vorslova Laboratory geneticist; Children’s Clinical University Hospital (Latvia)
Overview of Newborn Screening in Latvia
STAKEHOLDER SESSION
10:30-11:30 Smart Specialisation in Biomedicine (Conference room 1)
Moderator:
Lauma Muižniece
Director of Latvian Council of Science (Latvia)
Panel:
STAKEHOLDER SESSION
10:30-11:40 Excellence scholarship in bioinformatics – 5th anniversary (in Latvian)
(Conference Room 2)
STAKEHOLDER SESSION
11:40-12:40 Investors Roundtable
(Conference Room 2)
12:00-13:00 Lunch and networking
13:00-14:30 Pharmacogenomics (Conference Room 1)
Chair: Una Riekstina
Speakers:
Aris Saoulidis Senior Pharmacist; East Genomics (UK)
Integrating pharmacogenomic DPYD testing in routine NHS care
Elina Sivina Oncologist, Chemotherapist; Riga Stradins University (Latvia)
Latvian experience with personalized medication selection for the treatment of oncology patients (e.g., the need for DPYD testing and more)
Renate Ranka Associate Professor; Riga Stradins University (Latvia)
Pharmacogenetics of drug-induced liver injury: insights from tuberculosis studies
Mikko Niemi Professor; University of Helsinki (Finland)
Pharmacogenetics of lipid-lowering therapy
STAKEHOLDER SESSION
13:00-14:30 Health innovations (Conference Room 2)
Chair: Emil Syundyukov
Speakers:
Jaanus Pikani
Michael Akhras